OpenNeedle Ask your own

Question explored with the scientific record

Conversation so far

  1. 1 What are the benefits of viewing red light at 670nm
  2. 2 Are there any human studies on 670 nm eye exposure specifically?

Answered on this page ↓

Are there any human studies on 670 nm eye exposure specifically?

Oct 22, 2026 · 2 sources used · OpenNeedle synthesis
The short version: yes, human trials of 670 nm light reaching the eye exist, but none of the 14 records here is one of them.

I have to correct my last answer. I said the records contained no human trial of viewing 670 nm light. That was true of that search. It is not true of the world: human studies of red and near-infrared light aimed at the eye do exist outside this retrieval, and I cannot confirm their specifics from memory. What I can say is that this search still did not surface one.

What it did surface is skin, not eyes. A 2026 scoping review of red and near-infrared light for scars includes a randomized split-scar trial in children using 633–670 nm LED, with better scar scores than untreated areas and no reported adverse events [1]. A second trial used 670 nm on adult burn scars and reported improvement [1]. Both are light on skin, not light viewed by the eye, and both are small [1].

The safety picture for light therapy generally is not empty. A systematic review of photobiomodulation in cancer patients found no sign that it worsened tumor outcomes at recommended doses, though very high doses stimulated melanoma growth in one mouse model [2]. That is a caution about dose, not a verdict on eye exposure.

RecordSubjectWavelengthRelevance to eye
[1]Children, burn scars633–670 nmSkin only
[1]Adults, burn scars670 nmSkin only
[2]Cancer patients, animals660–830 nmNot eye

My call: human eye studies of 670 nm almost certainly exist outside this retrieval, but nothing in front of me tests viewing it, so I cannot tell you what they found. Confidence: low.

Keep digging

Sources used 2

  1. Red and near-infrared photobiomodulation for burn, hypertrophic, and post-surgical scars: a scoping review of clinical trials Lasers in Medical Science (2026) Thin

    Red and near-infrared photobiomodulation using LED or LLLT shows wavelength- and dose-dependent improvements in burn, hypertrophic, and post-surgical scars with good safety, but current evidence is limited by small, heterogeneous trials and lack of standardized dosing.

    DOI: 10.1007/s10103-026-04875-8
  2. Safety and efficacy of photobiomodulation therapy in oncology: A systematic review Cancer Medicine (2020) systematic review Strong

    In a PRISMA systematic review of 43 in vitro, 15 in vivo, and 9 clinical studies, photobiomodulation therapy appears safe with recommended parameters in clinical and animal studies, while in vitro findings on tumor-cell proliferation are conflicting.

    DOI: 10.1002/cam4.3582

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question →